CESSATECH A/S DK -20 Market Cap ($22.85 Million)
Market Cap & Net Worth: CESSATECH A/S DK -20 (8GN)
CESSATECH A/S DK -20 market cap. CESSATECH A/S DK -20 (F:8GN) has a market capitalization of $22.85 Million (€19.54 Million) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #24559 globally and #2126 in its home market, demonstrating a -2.70% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CESSATECH A/S DK -20's stock price €1.08 by its total outstanding shares 18576437 (18.58 Million). Also see CESSATECH A/S DK -20 cash conversion from operations for how efficiently the company converts equity into cash flow.
CESSATECH A/S DK -20 Market Cap History (2021–2026)
CESSATECH A/S DK -20 market cap history from 2021 to 2026. Data shows change from $51.58 Million to $23.46 Million (-15.99% CAGR). Check today's stock price for CESSATECH A/S DK -20 for real-time trading data and today's change.
CESSATECH A/S DK -20 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CESSATECH A/S DK -20's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 8GN shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
8.36x
CESSATECH A/S DK -20's market cap is 8.36 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $31.60 Million | $2.49 Million | -$14.67 Million | 12.71x | N/A |
| 2025 | $47.78 Million | $5.72 Million | -$10.90 Million | 8.36x | N/A |
Competitor Companies of 8GN by Market Capitalization
Companies near CESSATECH A/S DK -20 in the global market cap rankings as of November 3, 2026. Also see total assets of CESSATECH A/S DK -20 for a full breakdown of the balance sheet.
Key companies related to CESSATECH A/S DK -20 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of CESSATECH A/S DK -20 (2021–2026)
Market capitalization of CESSATECH A/S DK -20 from 2021 to today. Between 2021 and today, CESSATECH A/S DK -20's market cap moved from $51.58 Million to $ 23.46 Million, with a yearly change of -15.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €23.46 Million | -50.91% |
| 2025 | €47.78 Million | +51.20% |
| 2024 | €31.60 Million | +85.59% |
| 2023 | €17.03 Million | +310.47% |
| 2022 | €4.15 Million | -91.96% |
| 2021 | €51.58 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of CESSATECH A/S DK -20 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $22.85 Million USD |
| MoneyControl | $22.85 Million USD |
| MarketWatch | $22.85 Million USD |
| marketcap.company | $22.85 Million USD |
| Reuters | $22.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CESSATECH A/S DK -20
Cessatech A/S, a pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark. Its lead candidate product is CT001, a fixed-dose nasal spray for treating acute pain in children. The company also develops CT002, a non-invasive intranasal sedation for children undergoing medical procedures in Phase 2 clinical trials; and CT003, a topical anesthetic in pre-c… Read more